Skip to main content
2025 STS Annual Meeting Main banner

Critical Care and Perioperative Management

Early Career Surgeons

Controversies in Anticoagulation and HIT After Cardiac Surgery

Sunday, January 26, 2025
8:00am - 9:30am PT
Location: 409AB

    Moderator(s)

  • Milan Milojevic, MD, PhD, MSCE, FESC

    Senior Scientific Advisor
    Dedinje Cardiovascular Institute Belgrade
    Dedinje Cardiovascular Institute, University of Belgrade

    Disclosure(s): No financial relationships to disclose

  • Ahmet Kilic, MD (he/him/his)

    The Johns Hopkins Hospital
    Baltimore, Maryland, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests..

Disclosure(s):
Milan Milojevic, MD, PhD, MSCE, FESC: No financial relationships to disclose
Ravi K. Ghanta, MD: No financial relationships to disclose

Presentations:

  • 8:00am - 8:05am PT
    Case Presentation with Audience Polling

    Invited Speaker: Sameer Hirji, MD MPH – Brigham and Women's Hospital

  • 8:05am - 8:13am PT
    Landscape of HIT After Cardiac Surgery—Incidence and Outcomes

    Invited Speaker: Irsa Hasan, MD – University of Pittsburgh Medical Center

  • 8:13am - 8:21am PT
    Diagnosis of HIT After Cardiac Surgery—How Good is the 4T Score?

    Invited Speaker: Subhasis Chatterjee, MD – Baylor College of Medicine

  • 8:21am - 8:31am PT
    Venous Thromboembolism After Coronary Artery Bypass Increases Healthcare Costs: A Propensity Score Matched Analysis

    Presenting Author: Alex M. Wisniewski, MD, MSc – University of Virginia

  • 8:31am - 8:39am PT
    When Should You Switch From Heparin, and What Is the Best Alternative?

    Invited Speaker: Natalie Roy, MD – Boston Children's Hospital

  • 8:39am - 8:47am PT
    Your Patient with HIT Needs Cardiac Surgery. Now What?

    Invited Speaker: Dave C. Fitzgerald, DHA,MPH,CCP – Medical University of South Carolina

  • 8:47am - 8:57am PT
    Interim Data Analysis-—Heparin vs. Bivalirudin and ECMO Oxygenator Performance

    Presenting Author: Deep P. Vakil, MD (he/him/his) – Memorial Healthcare System

  • 8:57am - 9:03am PT
    Debate: Heparin Is the Anticoagulant of Choice in the CTICU

    Invited Speaker: Osamudiamen Obanor, MD (he/him/his) – University of Texas Health Sciences- Houston

  • 9:03am - 9:09am PT
    Debate: Bivalirudin is the Anticoagulant of Choice in the CTICU

    Invited Speaker: Glenn Whitman, MD (he/him/his) – Johns Hopkins Hospital

  • 9:09am - 9:15am PT
    Rebuttals
  • 9:15am - 9:30am PT
    Moderated Panel Discussion